85 related articles for article (PubMed ID: 36145636)
1. Influence of
Wang Y; Chen M; Chen H; Wang F
Front Pharmacol; 2021; 12():639854. PubMed ID: 33935730
[No Abstract] [Full Text] [Related]
2. Association between genetic polymorphisms in fibrinogen genes and bleeding risk in patients treated with direct oral anticoagulants.
Choi KH; Yee J; Song TJ; Park J; Gwak HS
Ann Acad Med Singap; 2023 Jul; 52(7):340-347. PubMed ID: 38904499
[TBL] [Abstract][Full Text] [Related]
3. Association between coenzyme Q 10-related genetic polymorphisms and statin-associated myotoxicity in Korean stroke patients.
Park YA; Chang Y; Lee DH; Kim JS; Park M; Choi SA; Song TJ; Gwak HS
Front Pharmacol; 2024; 15():1358567. PubMed ID: 38774208
[TBL] [Abstract][Full Text] [Related]
4. Common P-glycoprotein (
Slišković AM; Palić J; Božina T; Ganoci L; Vrkić Kirhmajer M; Trkulja V; Bulum J; Šimičević L
Biochem Med (Zagreb); 2024 Jun; 34(2):020703. PubMed ID: 38665866
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic Approach for the Prevention of Rivaroxaban's ADRs: A Systematic Review and Meta-Analysis.
Mardi P; Abbasi B; Shafiee A; Afsharmoghaddam T
Genet Res (Camb); 2023; 2023():6105320. PubMed ID: 37942082
[TBL] [Abstract][Full Text] [Related]
6. Association Studies in Clinical Pharmacogenetics.
Zubiaur P; Abad-Santos F
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678742
[TBL] [Abstract][Full Text] [Related]
7. Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia.
Cheng F; Cui Z; Li Q; Chen S; Li W; Zhang Y
Int Immunopharmacol; 2024 May; 133():112090. PubMed ID: 38640718
[TBL] [Abstract][Full Text] [Related]
8. Effect of Genotype on the Pharmacokinetics and Bleeding Events of Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
Shi J; Wu T; Wu S; Chen X; Ye Q; Zhang J
J Clin Pharmacol; 2023 Mar; 63(3):277-287. PubMed ID: 36309848
[TBL] [Abstract][Full Text] [Related]
9. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
[TBL] [Abstract][Full Text] [Related]
10. Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants.
Yoon HY; Song TJ; Yee J; Park J; Gwak HS
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145636
[No Abstract] [Full Text] [Related]
11. Construction of a risk scoring system using clinical factors and
Jang EJ; Kim JS; Choi SA; Yee J; Song TJ; Park J; Gwak HS
Front Pharmacol; 2023; 14():1290785. PubMed ID: 38034995
[No Abstract] [Full Text] [Related]
12. Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban.
Han JM; Jang EJ; Yee J; Song TJ; Kim DH; Park J; Gwak HS
Sci Rep; 2023 Sep; 13(1):15967. PubMed ID: 37749323
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
